Valuation: PolyNovo Limited

Market Cap 591M 413M 363M 337M 310M 582M 39.78B 4.01B 1.57B 19.56B 1.55B 1.52B 67.62B P/E 2026 *
81.1x
P/E 2027 * 30.5x
Enterprise Value 565M 395M 347M 323M 296M 557M 38.06B 3.83B 1.5B 18.71B 1.48B 1.45B 64.69B EV / Sales 2026 *
3.82x
EV / Sales 2027 * 3.03x
Free-Float
88.97%
Yield 2026 *
-
Yield 2027 * -
1 day-7.57%
1 week-12.76%
Current month-7.07%
1 month-9.52%
3 months-14.93%
6 months-21.56%
Current year-30.49%
1 week 0.83
Extreme 0.83
1
1 month 0.83
Extreme 0.83
1.04
Current year 0.83
Extreme 0.83
1.3
1 year 0.83
Extreme 0.83
1.66
3 years 0.83
Extreme 0.83
2.78
5 years 0.83
Extreme 0.83
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 2025-11-30
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman - 2025-10-26
Director/Board Member 65 2019-10-27
Director/Board Member - 2020-05-12
Date Insider Type Main position Quantity % Market Cap.
3/16/26 Buy

Director

151,000 0.0219%
2/27/26 Buy

Director

100,000 0.0145%
2/27/26 Buy

Chairman

30,000 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
-7.57%-12.76%-33.72%-45.89% 413M
+2.29%+2.36%-18.56%-8.74% 180B
+1.46%+0.01%-10.47%-6.46% 107B
+1.58%+0.65%+6.73%+61.49% 60.29B
-1.13%-2.60%+27.02%+55.00% 50.19B
+2.22%-1.14%-15.63%-44.81% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-44.95% 27.61B
-7.67%-8.39%+24.55%-12.97% 23.1B
+1.63%-1.73%-7.11%-8.13% 20.86B
Average -0.27%-3.29%-5.20%-6.16% 54.43B
Weighted average by Cap. +1.27%-0.41%-6.83%+1.08%

Financials

2026 *2027 *
Net sales 148M 104M 90.96M 84.59M 77.63M 146M 9.97B 1B 392M 4.9B 389M 380M 16.95B 181M 127M 111M 104M 95.11M 179M 12.22B 1.23B 481M 6.01B 476M 466M 20.77B
Net income 6.9M 4.82M 4.24M 3.94M 3.62M 6.79M 465M 46.79M 18.28M 228M 18.11M 17.72M 790M 19.25M 13.46M 11.82M 10.99M 10.09M 18.95M 1.3B 131M 51M 637M 50.52M 49.43M 2.2B
Net Debt -25.56M -17.88M -15.7M -14.6M -13.4M -25.17M -1.72B -173M -67.74M -846M -67.11M -65.66M -2.93B -41.66M -29.13M -25.58M -23.79M -21.83M -41.02M -2.81B -283M -110M -1.38B -109M -107M -4.77B
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
26-07-24 A$0.8550 -7.57% 8,190,309
26-07-23 A$0.9250 -2.63% 7,477,652
26-07-22 A$0.9500 0.00% 829,666
26-07-21 A$0.9500 -2.06% 1,115,704
26-07-20 A$0.9700 -1.02% 1,230,568
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
0.8550AUD
Average target price
1.691AUD
Spread / Average Target
+97.81%

Quarterly revenue - Rate of surprise